Martin Empting

23PUBLICATIONS
69CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsProteins and peptidesBiomolecular modelling and designMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 24, 2026
Phenazine Biosynthesis Inhibitors as Pseudomonas aeruginosa Antivirulence Agents.

|Nov 18, 2025
Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen.

Aylin Berwanger, Saskia Catherina Stein, Sarah Brandner

|May 15, 2025
Tandem ketone reduction in pepstatin biosynthesis reveals an F420H2-dependent statine pathway.

Jingjun Mo, Asfandyar Sikandar, Haowen Zhao

|Apr 11, 2025
Domain adaptable language modeling of chemical compounds identifies potent pathoblockers for Pseudomonas aeruginosa.

Georgios Kallergis, Ehsannedin Asgari, Martin Empting

|May 06, 2024
Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?

Noha Nafee, Dina M Gaber, Alaa Abouelfetouh

|Feb 08, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak

Pageof 4

Frequent Collaborators

6 joint publications

Anna Katharina Herta Hirsch

6 joint publications

Andreas Martin Kany

4 joint publications

Wulf Blankenfeldt

4 joint publications

Claus-Michael Lehr